Latest Technology News

Ionic Rare Earths’ Brazilian joint venture, Viridion, has been selected for significant government funding to accelerate rare earth refining and magnet recycling, marking a major step in Brazil’s strategic push for a secure, sustainable supply chain.

Norfolk Metals has cleared all hurdles to begin Stage 1 of its earn-in agreement for the Carmen Copper Project in Chile, committing $3 million over three years to secure a 70% stake. The company has also completed a key share issuance following shareholder approval.

ASPI Isotopes Inc. has proposed a scheme to acquire all Renergen shares at a 41.3% premium, aiming to create a global critical materials powerhouse. The deal, subject to shareholder and regulatory approval, will delist Renergen from multiple exchanges.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

PointsBet Holdings has secured Foreign Investment Review Board approval for MIXI Australia's proposed full acquisition, marking a key regulatory milestone in the takeover process.

Harmoney’s founder Neil Roberts has sold 3.6 million shares, reducing his stake to 15%, as he transitions from Chief Strategy Officer to a non-executive director role.

BetMakers Technology Group has successfully raised $11.5 million through a share placement aimed at repaying debt and funding strategic growth initiatives, including a potential acquisition in Nevada.

Ragusa Minerals has terminated its binding agreement with Geopolymer Industries due to unmet conditions, reaffirming its commitment to the Burracoppin rare earths project and exploring fresh opportunities.

Mesoblast reports positive FDA progress on accelerated approval for Revascor in ischemic heart failure and plans a pivotal trial to extend Ryoncil’s label to adults with graft versus host disease, while its US commercial launch outpaces expectations.

HITIQ has partnered exclusively with Shock Doctor to launch the PROTEQT instrumented mouthguard, aiming to transform concussion management worldwide. The company also initiates a $2.92 million rights issue to fuel this ambitious rollout.

EV Resources Limited has finalized its acquisition of a 70% interest in the Los Lirios Antimony Mine in Oaxaca, Mexico, marking a strategic move to bolster critical mineral supply in the Americas. The company is advancing ore testing and plans to develop processing capabilities aligned with local community priorities.

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.